Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Radboud University Medical Center · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
monoclonal-antibody
metastatic clear cell renal cell carcinoma, advanced renal cell carcinoma, clear cell renal cell carcinoma (ccrcc), lutetium-177, lu-177, girentuximab, cg250, monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 837252
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.